Chronos CEO wins European CEO, Best CEO in the Drug Discovery Industry
Chronos CEO, Dr Huw Jones has been awarded best CEO in the European drug discovery industry by online and print magazine European CEO. Read the press release.
Chronos CEO, Dr Huw Jones has been awarded best CEO in the European drug discovery industry by online and print magazine European CEO. Read the press release.
Dr Schulz-Utermoehl has over 17 years’ experience in the pharmaceutical industry, spanning early and late-stage discovery research and pre-clinical development. He and Dr Fraser Murray will be [...]
Dr Murray brings more than 20 years’ of drug discovery and early development experience across a range of therapeutic areas, including neurodegeneration, psychiatry, inflammation and [...]
Chronos has acquired three pre-clinical programmes from a subsidiary of Shire PLC in a transformative transaction. All intellectual property, know-how, development and marketing rights are [...]
Chronos joins Oxford Biodynamics and The Nuffield Department of Clinical Neurosciences, Oxford in search for better diagnosis and prognosis of ALS in a programme valued at £1.26m. Read the press [...]
Chronos Therapeutics Ltd completes major fund raise in an over-subscribed round. Funding will support the acceleration of lead compound into neurodegenerative disease. Read the press release.
Call: +44 (0) 1865 309 500
Enquiries: info@chronostherapeutics.com